June 30, 2021 07:25 AM EDTUpdated 09:33 AM
Coronavirus

Covid-19 roundup: GSK and Vir reach sotro­vimab sup­ply agree­ment in Sin­ga­pore; J&J vac­cine shows var­ied suc­cess against vari­ants

Josh Sullivan

GSK Sin­ga­pore and Vir Biotech­nol­o­gy have reached an agree­ment with the Sin­ga­pore gov­ern­ment to sup­ply it with a sin­gle-dose mon­o­clon­al an­ti­body for Covid-19.

GSK has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times